X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (463421) 463421
Newspaper Article (50476) 50476
Newsletter (24550) 24550
Magazine Article (4878) 4878
Book Chapter (1560) 1560
Book / eBook (1038) 1038
Trade Publication Article (624) 624
Web Resource (468) 468
Transcript (412) 412
Book Review (165) 165
Conference Proceeding (124) 124
Reference (113) 113
Dissertation (83) 83
Publication (83) 83
Report (83) 83
Streaming Video (53) 53
Government Document (44) 44
Paper (44) 44
Journal / eJournal (13) 13
Video Recording (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (358820) 358820
index medicus (188321) 188321
female (181224) 181224
male (180567) 180567
adult (128794) 128794
infections (109277) 109277
middle aged (107857) 107857
infectious diseases (94969) 94969
infection (87936) 87936
health aspects (71361) 71361
animals (66326) 66326
aged (64942) 64942
anti-bacterial agents - therapeutic use (59775) 59775
research (58820) 58820
hiv infections - drug therapy (55817) 55817
microbiology (55005) 55005
immunology (53942) 53942
adolescent (50306) 50306
hiv (50203) 50203
antibiotics (48787) 48787
risk factors (48121) 48121
drug therapy (47858) 47858
treatment outcome (45039) 45039
child (41713) 41713
care and treatment (39775) 39775
pharmacology & pharmacy (36883) 36883
analysis (31421) 31421
human immunodeficiency virus--hiv (31284) 31284
mortality (31037) 31037
hiv infection (30693) 30693
medical research (29954) 29954
drug resistance (29866) 29866
therapy (29608) 29608
child, preschool (29300) 29300
retrospective studies (29236) 29236
patients (28157) 28157
medicine (27985) 27985
bacterial infections (27894) 27894
medicine, general & internal (27775) 27775
drug therapy, combination (27517) 27517
young adult (27036) 27036
epidemiology (27035) 27035
diagnosis (26955) 26955
microbial sensitivity tests (26492) 26492
research article (26393) 26393
bacteria (26332) 26332
infant (26292) 26292
aids (25969) 25969
prevalence (25245) 25245
prevention (24626) 24626
virology (24481) 24481
disease (24214) 24214
anti-bacterial agents - pharmacology (22909) 22909
mice (22569) 22569
anti-hiv agents - therapeutic use (22361) 22361
bacterial infections - drug therapy (21611) 21611
medicine, experimental (21604) 21604
pediatrics (21309) 21309
viruses (20935) 20935
antiviral agents (20537) 20537
children (20479) 20479
aged, 80 and over (20410) 20410
prospective studies (20366) 20366
surgery (20254) 20254
studies (20217) 20217
hiv infections - complications (20204) 20204
antiretroviral therapy (19934) 19934
clinical trials (18747) 18747
time factors (18547) 18547
antiviral agents - therapeutic use (18412) 18412
cancer (18125) 18125
hospitals (17962) 17962
gastroenterology & hepatology (17847) 17847
public, environmental & occupational health (17131) 17131
tuberculosis (16987) 16987
viral load (16701) 16701
anti-bacterial agents - administration & dosage (16689) 16689
medicine & public health (16477) 16477
infant, newborn (16186) 16186
pneumonia (16180) 16180
multidisciplinary sciences (16125) 16125
hepatitis (16113) 16113
hiv infections - virology (15970) 15970
management (15951) 15951
public health (15898) 15898
drugs (15847) 15847
pregnancy (15817) 15817
virus diseases (15712) 15712
risk (15303) 15303
acquired immune deficiency syndrome--aids (15261) 15261
usage (14993) 14993
drug resistance in microorganisms (14903) 14903
staphylococcal infections - drug therapy (14779) 14779
proteins (14653) 14653
hiv infections - epidemiology (14297) 14297
oncology (14273) 14273
resistance (14111) 14111
follow-up studies (14095) 14095
internal medicine (13524) 13524
incidence (13487) 13487
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (417) 417
Online Resources - Online (166) 166
Collection Dvlpm't (Acquisitions) - Vendor file (75) 75
Collection Dvlpm't (Acquisitions) - Closed Orders (32) 32
UofT at Scarborough - Stacks (28) 28
UofT at Mississauga - Stacks (22) 22
St. Michael's Hospital - Stacks (20) 20
New College (Ivey) - Stacks (13) 13
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (13) 13
Scarborough Hospital - Birchmount (10) 10
Scarborough Hospital - General (9) 9
Gerstein Science - Circulation Desk (7) 7
St. Michael's College (John M. Kelly) - 2nd Floor (7) 7
Lakeridge Health Sciences - Oshawa (6) 6
Thomas Fisher Rare Book - Rare Book (6) 6
Providence Healthcare - Stacks (5) 5
Robarts - Stacks (5) 5
Scarborough Hospital - Online (5) 5
UTL at Downsview - May be requested (5) 5
West Park Healthcare Centre - Stacks (4) 4
Earth Sciences (Noranda) - Stacks (3) 3
Gerstein Science - Missing (3) 3
Gerstein Science - Periodical Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (2) 2
Gerstein Science - Bindery (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Law (Bora Laskin) - Stacks (2) 2
Media Commons - Audio Visual (2) 2
Media Commons - Microtexts (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (2) 2
University College (Laidlaw) - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Oversize (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Reserve desk (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Law (Bora Laskin) - Theses (1) 1
New College (Ivey) - Not returned (1) 1
OISE - Stacks (1) 1
OISE - Theses (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Scarborough Hospital - Withdrawn (1) 1
St Josephs Health Centre - Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Circulation Desk (1) 1
UofT at Scarborough - Bindery (1) 1
UofT at Scarborough - Circulation Desk (1) 1
Victoria University E.J. Pratt - Circulation Desk (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (510497) 510497
German (7932) 7932
French (7831) 7831
Japanese (6185) 6185
Spanish (5619) 5619
Russian (4819) 4819
Italian (2176) 2176
Chinese (1522) 1522
Polish (1273) 1273
Portuguese (730) 730
Dutch (708) 708
Danish (556) 556
Czech (441) 441
Swedish (394) 394
Norwegian (365) 365
Turkish (335) 335
Hungarian (318) 318
Romanian (308) 308
Bulgarian (190) 190
Finnish (170) 170
Hebrew (170) 170
Croatian (168) 168
Ukrainian (165) 165
Korean (157) 157
Serbian (133) 133
Slovak (92) 92
Arabic (28) 28
Lithuanian (26) 26
Slovenian (17) 17
Icelandic (13) 13
Bosnian (9) 9
Afrikaans (8) 8
Urdu (6) 6
Hindi (4) 4
Persian (4) 4
Greek (3) 3
Indonesian (2) 2
Latvian (2) 2
Estonian (1) 1
Sanskrit (1) 1
Sotho (1) 1
Zulu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 1537-6613, 2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters) tolerant to... 
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
Journal of Virology, ISSN 0022-538X, 2016, Volume 90, Issue 21, pp. 9683 - 9692
... resistance to antiviral therapies. The recent emergence of chikungunya virus, Zika virus, and Ebola virus highlights the struggles to contain outbreaks... 
DRUG | EFLORNITHINE | REPLICATION | VIROLOGY | ALPHA-DIFLUOROMETHYLORNITHINE | DEPLETION | INFECTION | TRANSLATION | MAMMALIAN-CELLS | RESPIRATORY SYNDROME CORONAVIRUS | SPERMIDINE | Zika Virus Infection - drug therapy | Acetyltransferases - metabolism | Ebolavirus - metabolism | Chikungunya virus - metabolism | Humans | Eflornithine - pharmacology | Ebolavirus - drug effects | Zika Virus Infection - virology | Disease Outbreaks | RNA Viruses - drug effects | Hemorrhagic Fever, Ebola - virology | Hemorrhagic Fever, Ebola - drug therapy | Spermine - analogs & derivatives | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Mice, Inbred C57BL | Chikungunya Fever - drug therapy | Zika Virus - drug effects | Chikungunya Fever - virology | Polyamines - metabolism | Chikungunya virus - drug effects | Animals | Spermine - pharmacology | Mice | Spermine/analogs & derivatives | Virus Replication/drug effects | Hemorrhagic Fever, Ebola/virology | Life Sciences | Zika Virus/drug effects | Immunology | Chikungunya virus/metabolism | Chikungunya Fever/drug therapy | Zika Virus Infection/drug therapy | Ebolavirus/drug effects | Acetyltransferases/metabolism | Chikungunya virus/drug effects | Eflornithine/pharmacology | Spermine/pharmacology | Polyamines/metabolism | Chikungunya Fever/virology | Hemorrhagic Fever, Ebola/drug therapy | Virology | Microbiology and Parasitology | Zika Virus Infection/virology | Ebolavirus/metabolism | Antiviral Agents/pharmacology | RNA Viruses/drug effects
Journal Article
American Family Physician, ISSN 0002-838X, 2010, Volume 81, Issue 2, pp. 137 - 144
Red eye is the cardinal sign of ocular inflammation. The condition is usually benign and can be managed by primary care physicians. Conjunctivitis is the most... 
Internal Medicine | TRIAL | DROPS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | SIGNS | RESISTANCE | ACUTE BACTERIAL CONJUNCTIVITIS | PRIMARY HEALTH CARE | TOPICAL ANTIBIOTICS | INFECTIOUS CONJUNCTIVITIS | STRATEGIES | CHILDREN | Corneal Diseases - therapy | Eye Burns - drug therapy | Glucocorticoids - therapeutic use | Primary Health Care - methods | Corneal Ulcer - therapy | Humans | Eye Infections - drug therapy | Eye Foreign Bodies - drug therapy | Eye Burns - therapy | Keratoconjunctivitis - diagnosis | Anti-Bacterial Agents - therapeutic use | Blepharitis - drug therapy | Endophthalmitis - therapy | Blepharitis - therapy | Endophthalmitis - drug therapy | Diagnosis, Differential | Dry Eye Syndromes - drug therapy | Corneal Diseases - drug therapy | Eye Foreign Bodies - therapy | Glaucoma - drug therapy | Burns, Chemical - therapy | Glaucoma - diagnosis | Eye Diseases - diagnosis | Corneal Ulcer - drug therapy | Keratoconjunctivitis - drug therapy | Eye Infections - therapy | Algorithms | Eye Diseases - drug therapy | Eye Injuries - drug therapy | Burns, Chemical - drug therapy | Dry Eye Syndromes - therapy | Eye Injuries - therapy | Family Practice - methods | Eye Diseases - therapy | Care and treatment | Ocular manifestations of general diseases | Ophthalmic drugs | Causes of | Dosage and administration | Diagnosis | Conjunctivitis
Journal Article
Journal of infection and chemotherapy, ISSN 1341-321X, 1995
Journal
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 530, Issue 7588, pp. 51 - 56
.... Although combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral... 
EVOLUTION | SEQUENCE DATA | COMBINATION THERAPY | DNA | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4(+) T-CELLS | PERIPHERAL-BLOOD | INFECTION | Anti-HIV Agents - pharmacology | Carrier State - blood | Humans | Molecular Sequence Data | Phylogeny | Selection, Genetic - drug effects | Anti-HIV Agents - administration & dosage | HIV-1 - growth & development | Time Factors | HIV-1 - isolation & purification | Haplotypes - drug effects | Anti-HIV Agents - therapeutic use | Lymph Nodes - drug effects | Spatio-Temporal Analysis | HIV Infections - blood | Virus Replication - drug effects | HIV-1 - drug effects | HIV Infections - virology | Lymph Nodes - virology | HIV-1 - genetics | Sequence Analysis, DNA | Carrier State - virology | Models, Biological | Carrier State - drug therapy | Drug Resistance, Viral - drug effects | HIV Infections - drug therapy | Viral Load - drug effects | Infection | Highly active antiretroviral therapy | Care and treatment | Analysis | Patient outcomes | Physiological aspects | Development and progression | HIV (Viruses) | Health aspects | HIV infection | Haplotypes | Antiretroviral drugs | Tissue | Lymphatic system | Human immunodeficiency virus--HIV | Phylogenetics | Infections | Drug resistance
Journal Article
PLoS pathogens, ISSN 1553-7374, 2015, Volume 11, Issue 9, p. e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
ACTIVATION | RNA | PERSISTENCE | CD4(+) T-CELLS | MICROBIOLOGY | VIROLOGY | HISTONE DEACETYLASES | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | STEM-CELL | INFECTION | PARASITOLOGY | VIRAL RESERVOIR | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 2018, Volume 24, Issue 12, pp. 1339.e1 - 1339.e5
...) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing... 
Listeria monocytogenes | Listeriosis | Pleural effusion | Immunosuppression | Pneumonia | INFECTIOUS DISEASES | MANAGEMENT | SERIES | SURVEILLANCE | EFFUSION | MICROBIOLOGY | CENTRAL-NERVOUS-SYSTEM | Listeriosis - drug therapy | Sepsis - etiology | Lung Diseases - microbiology | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Male | Lung Diseases - drug therapy | Lung Diseases - etiology | Empyema, Pleural - epidemiology | Listeriosis - epidemiology | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Pleuropneumonia - epidemiology | Aged, 80 and over | Adult | Female | Respiratory Tract Infections - etiology | Retrospective Studies | Pleuropneumonia - drug therapy | Pleuropneumonia - etiology | Pneumonia, Bacterial - microbiology | Listeriosis - complications | Empyema, Pleural - microbiology | Sepsis - epidemiology | Listeria monocytogenes - isolation & purification | Respiratory Tract Infections - drug therapy | Pleuropneumonia - microbiology | Pneumonia, Bacterial - epidemiology | Empyema, Pleural - drug therapy | Listeriosis - microbiology | Pneumonia, Bacterial - drug therapy | Aged | Respiratory Tract Infections - epidemiology | Empyema, Pleural - etiology | Lung Diseases - epidemiology | Sepsis - microbiology | Listeria monocytogenes - drug effects | Pneumonia, Bacterial/etiology | Lung Diseases/epidemiology | Sepsis/drug therapy | Empyema, Pleural/epidemiology | Listeriosis/drug therapy | Sepsis/microbiology | Lung Diseases/microbiology | Pneumonia, Bacterial/epidemiology | Lung Diseases/etiology | Life Sciences | Listeriosis/microbiology | Pneumonia, Bacterial/drug therapy | Sepsis/epidemiology | Pleuropneumonia/epidemiology | Pleuropneumonia/etiology | Respiratory Tract Infections/drug therapy | Lung Diseases/drug therapy | Empyema, Pleural/drug therapy | Listeria monocytogenes/isolation & purification | Pleuropneumonia/drug therapy | Listeria monocytogenes/drug effects | Respiratory Tract Infections/epidemiology | Pleuropneumonia/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Respiratory Tract Infections/etiology | Respiratory Tract Infections/microbiology | Listeriosis/complications | Empyema, Pleural/etiology | Empyema, Pleural/microbiology | Listeriosis/epidemiology | Pneumonia, Bacterial/microbiology | Anti-Bacterial Agents/therapeutic use | Sepsis/etiology
Journal Article
Nature (London), ISSN 1476-4687, 2012, Volume 487, Issue 7408, pp. 482 - 485
Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1... 
CELLS | ACTIVATION | SUBEROYLANILIDE HYDROXAMIC ACID | MULTIDISCIPLINARY SCIENCES | IN-VIVO | VALPROIC ACID | INFECTION | HISTONE DEACETYLASE INHIBITORS | TYPE-1 | EXPRESSION | PCR | Gene Expression Regulation, Viral - drug effects | Humans | Hydroxamic Acids - adverse effects | Histone Deacetylase Inhibitors - administration & dosage | RNA, Viral - blood | Virus Latency - drug effects | Proviruses - drug effects | HIV-1 - growth & development | Proviruses - genetics | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | CD4-Positive T-Lymphocytes - virology | Hydroxamic Acids - pharmacology | Biomarkers - metabolism | HIV Infections - blood | Risk Assessment | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | RNA, Viral - biosynthesis | CD4-Positive T-Lymphocytes - metabolism | Viremia - drug therapy | HIV-1 - genetics | Proviruses - growth & development | Histones - drug effects | Up-Regulation - drug effects | Acetylation - drug effects | Viremia - virology | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Histones - metabolism | CD4-Positive T-Lymphocytes - drug effects | Histone Deacetylase Inhibitors - adverse effects | Physiological aspects | Antiviral agents | HIV patients | Health aspects | Vorinostat | Antiretroviral drugs | Plasma | Cell culture | Lymphocytes | Human immunodeficiency virus--HIV | Genomes | Drug therapy | Drug dosages
Journal Article